We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
ANI Pharmaceuticals
ANIP
$1.78B
| $2.52M | ﹤0.01% |
42,210
+40
| +0.1% | +$2.44K |
|
1777
Aspen Aerogels
ASPN
$518M
| $2.51M | ﹤0.01% |
90,490
-2,736
| -3% | -$68.5K |
|
|
SVC
1778
Service Properties Trust
SVC
$1.07B
| $2.49M | ﹤0.01% |
109,404
-1,362
| -1% | -$33.9K |
|
|
SPTN
1779
DELISTED
SpartanNash
SPTN
| $2.49M | ﹤0.01% |
111,192
-3,748
| -3% | -$77.3K |
|
1780
CareDx
CDNA
$2.42B
| $2.49M | ﹤0.01% |
79,750
-4,409
| -5% | -$110K |
|
1781
TriCo Bancshares
TCBK
$1.83B
| $2.49M | ﹤0.01% |
58,381
-4,744
| -8% | -$205K |
|
1782
1st Source
SRCE
$2.12B
| $2.49M | ﹤0.01% |
41,577
-6,467
| -13% | -$381K |
|
1783
Century Aluminum
CENX
$5.07B
| $2.49M | ﹤0.01% |
153,132
-9,666
| -6% | -$146K |
|
|
SHOE
1784
Shoe Station Group
SHOE
$428M
| $2.48M | ﹤0.01% |
56,556
-155
| -0.3% | -$6.33K |
|
1785
10x Genomics
TXG
$6.61B
| $2.48M | ﹤0.01% |
109,757
+2,785
| +3% | +$57.6K |
|
1786
Forward Air
FWRD
$654M
| $2.48M | ﹤0.01% |
69,992
-19,465
| -22% | -$552K |
|
1787
Arcus Biosciences
RCUS
$3.64B
| $2.47M | ﹤0.01% |
161,835
-4,000
| -2% | -$63.1K |
|
1788
SFL Corp
SFL
$1.61B
| $2.47M | ﹤0.01% |
213,639
-2,036
| -0.9% | -$24.4K |
|
1789
Liberty Live Group Series C
LLYVK
$9.46B
| $2.47M | ﹤0.01% |
48,101
-582
| -1% | -$23.3K |
|
1790
Novavax
NVAX
$1.31B
| $2.47M | ﹤0.01% |
195,440
-4,469
| -2% | -$57.7K |
|
|
WSR
1791
DELISTED
Whitestone REIT
WSR
| $2.46M | ﹤0.01% |
182,121
+27,736
| +18% | +$372K |
|
|
HSII
1792
DELISTED
Heidrick & Struggles
HSII
| $2.46M | ﹤0.01% |
63,336
-1,241
| -2% | -$44.9K |
|
1793
Shell
SHEL
$245B
| $2.46M | ﹤0.01% |
37,312
+2,205
| +6% | +$156K |
|
|
GOGL
1794
DELISTED
Golden Ocean Group
GOGL
| $2.45M | ﹤0.01% |
182,893
-9,665
| -5% | -$120K |
|
1795
Kosmos Energy
KOS
$1.48B
| $2.44M | ﹤0.01% |
605,468
-66,744
| -10% | -$325K |
|
1796
IonQ
IONQ
$16.6B
| $2.43M | ﹤0.01% |
278,226
-17,692
| -6% | -$135K |
|
1797
Hain Celestial
HAIN
$53.7M
| $2.43M | ﹤0.01% |
281,737
-2,682
| -0.9% | -$20.1K |
|
1798
Pacira BioSciences
PCRX
$997M
| $2.43M | ﹤0.01% |
161,268
+1,801
| +1% | +$30.8K |
|
1799
IES Holdings
IESC
$15.2B
| $2.42M | ﹤0.01% |
12,126
-274
| -2% | -$44.4K |
|
1800
MannKind Corp
MNKD
$1.32B
| $2.41M | ﹤0.01% |
382,803
-14,391
| -4% | -$82.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.